9/29/2022 8:27:25 AM
ATyr Pharma Announces Notice Of Allowance For U.S. Patent For Anti-Neuropilin-2 Monoclonal Antibodies
9/13/2022 8:30:29 AM
ATyr Pharma Gets FDA Fast Track Designation For Efzofitimod For Treatment Of Lung Disease
9/13/2021 7:48:15 AM
ATyr Pharma Announces Phase 1b/2a Trial Of ATYR1923 Meets Primary Endpoint